Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
Breast Cancer Research and Treatment
|
August 10, 2007
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer
P Neven, B Van Calster, I Van den Bempt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 1, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors
T van Cann, T Loyson, A Verbiest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 8, 2021
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
D J Slamon, P Neven, S Chia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2025
Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial
K L Jhaveri, P Neven, M L Casalnuovo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Overall survival with abemaciclib in early breast cancer
S Johnston, M Martin, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2022
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer
K Van Baelen, T Geukens, M Maetens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2021
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
G Jerusalem, S Farah, A Courtois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 2025
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer
K Van Baelen, E Sawyer, J Van Cauwenberge, et al.
Clinical Pharmacology and Therapeutics
|
September 25, 2013
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations
M A Province, M P Goetz, H Brauch, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
Breast Cancer Research and Treatment
|
August 10, 2007
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer
P Neven, B Van Calster, I Van den Bempt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 1, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors
T van Cann, T Loyson, A Verbiest, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 8, 2021
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
D J Slamon, P Neven, S Chia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2025
Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial
K L Jhaveri, P Neven, M L Casalnuovo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Overall survival with abemaciclib in early breast cancer
S Johnston, M Martin, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2022
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer
K Van Baelen, T Geukens, M Maetens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2021
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
G Jerusalem, S Farah, A Courtois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 2025
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer
K Van Baelen, E Sawyer, J Van Cauwenberge, et al.
Clinical Pharmacology and Therapeutics
|
September 25, 2013
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations
M A Province, M P Goetz, H Brauch, et al.
Page
of 14